Children's Hospital Colorado

Depression and Insulin Sensitivity in Adolescents Research Study

Endocrinology | June 01, 2018
Diagnosis
Teenage girls who have a family member with type 2 diabetes or prediabetes.
Age
12 to 17
COMIRB number
16-2571
Compensation
Yes
Complete this form to be considered for the MIND study.

Researchers at Children's Hospital Colorado want to find ways to prevent type 2 diabetes. If you believe your teenage daughter or family member could be at risk for developing depression and type 2 diabetes, she may benefit from the Mood and Insulin Resistance for Diabetes (MIND) prevention research project.

Participating teens receive up to $665 as compensation for their time.

Purpose of study

The goal of this study is to see if helping teenage girls feel less stressed can decrease their chance of developing type 2 diabetes.

Our hope is that by managing depression – a risk factor for type 2 diabetes that is common in teenage girls – we can learn more about ways to prevent type 2 diabetes.

Research details

We are looking for girls who:

  • Are 12 to 17 years old
  • Have a family member with diabetes
  • Sometimes seem depressed or stressed

The possible benefits of participating in the MIND Project are:

  • Feeling happier and less stressed
  • Learning about leading a healthier life
  • Decreasing the chance of developing type 2 diabetes

Study procedures take place on the Anschutz Medical Campus of Children's Colorado in Aurora. The duration of participation is just over one year, and the procedures involved are:

  • Two screening visits
  • Tasks to do at home
  • A six-session after-school program that focuses on mood, stress and health information in a group setting. Sessions take place once per week for six weeks.
  • Two follow-up visits

Contact us

If you are interested in this research study and want to see if your daughter would be a good fit, please fill out this short form. For more information, contact us at 970-893-1582 or email our team.

Principal Investigator: Isabella Conte

RD0003FFC14BD3